Vanda Announces Resignation of Senior Legal Executive

2026-04-03 07:42:37

Abstract generation in progress

Vanda Pharmaceuticals announced the resignation of Timothy Williams, its Senior Vice President, General Counsel, and Secretary, effective April 10, 2026. This departure marks a significant change in the company’s executive legal leadership, potentially impacting its corporate governance and strategic matters. The company’s stock currently has a Hold rating with a $7.00 price target from analysts, while TipRanks’ AI Analyst Spark rates VNDA as Neutral due to weak financial performance despite strong technical momentum.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes